Other than Rash and pruritus, dermatologic toxic effects that may occur with the use of ICIs are bullous pemphigoid, Sweet syndrome, Stevens-Johnson syndrome/toxic epidermal necrolysis, Mucosal toxic effects, and Vitiligo, which are fairly rare and more often found in anti-PD-L1 antibodies 73. The gene discussed is CD274; the disease is sweet syndrome.